A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Edwards Lifesciences Corp’s current trading price is -5.29% away from its 52-week high, while its distance from the 52-week low is 30.28%. The stock’s price range for this time frame has been between $60.34 and $83.00. The trading volume of the company’s shares in the Healthcare reached around 3.96 million for the day, which was evidently lower than the average daily volume of 4.38 million over the last three months.
Edwards Lifesciences Corp (EW) currently has a stock price of $78.61. The stock saw a sharp increase in the last trading session, hitting a high of $101.0 after opening at $78.61. The lowest recorded price for the day was $72.0 before it closed at $79.24.
The stock market performance of Edwards Lifesciences Corp has been very steady.
How Financial Performance Impacts Market Capitalization
Edwards Lifesciences Corp (EW) has experienced a quarterly rise of 4.93% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 46.11B and boasts a workforce of 15800 employees.
Decoding Analysts’ Ratings for Edwards Lifesciences Corp
As of right now, 13 analysts are rating Edwards Lifesciences Corp as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 16 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 74.99, with a change in price of +10.66. Similarly, Edwards Lifesciences Corp recorded 4,586,435 in trading volume during the last 100 days, posting a change of +15.69%.
How EW’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for EW stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.06.
EW Stock Stochastic Average
The raw stochastic average for Edwards Lifesciences Corp over the last 50 days is presently at 58.50%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 43.02%. Further, the company’s Stochastic %K and %D values for the last 20 days were 52.15% and 54.33%, respectively.
EW Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a gain of 29.23%.However, over the last six months, we can see a weaker performance of 10.21%. Over the last 30 days, the price of EW has fallen by 2.91%. And in the last five days, it has fallen by -3.14%.
